US Stock MarketDetailed Quotes
ABT Abbott Laboratories
- 117.175
- +1.245+1.07%
Trading Nov 21 14:51 ET
203.23BMarket Cap35.62P/E (TTM)
117.260High115.140Low2.73MVolume115.500Open115.930Pre Close317.31MTurnover0.16%Turnover Ratio35.94P/E (Static)1.73BShares121.00052wk High5.11P/B201.96BFloat Cap99.24152wk Low2.16Dividend TTM1.72BShs Float134.798Historical High1.84%Div YieldTTM1.83%Amplitude6.460Historical Low116.092Avg Price1Lot Size
Abbott Laboratories Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.85%10.64B | 4.00%10.38B | 2.23%9.96B | -8.12%40.11B | 1.49%10.24B | -2.56%10.14B | -11.36%9.98B | -18.06%9.75B | 1.34%43.65B | -12.01%10.09B |
| Operating revenue | 4.85%10.64B | 4.00%10.38B | 2.23%9.96B | -8.12%40.11B | 1.49%10.24B | -2.56%10.14B | -11.36%9.98B | -18.06%9.75B | 1.34%43.65B | -12.01%10.09B |
| Cost of revenue | 2.02%4.7B | 2.68%4.6B | 3.05%4.46B | -6.10%17.98B | -0.81%4.56B | -0.52%4.61B | -9.12%4.48B | -13.15%4.33B | 3.26%19.14B | -3.63%4.59B |
| Gross profit | 7.20%5.94B | 5.08%5.77B | 1.57%5.5B | -9.70%22.13B | 3.40%5.69B | -4.20%5.54B | -13.11%5.5B | -21.60%5.42B | -0.11%24.51B | -17.96%5.5B |
| Operating expense | 4.81%4.08B | 3.85%4.11B | 5.32%4.12B | -3.05%15.66B | -6.89%3.91B | -2.99%3.89B | 0.13%3.95B | -2.23%3.91B | 0.22%16.15B | -3.01%4.19B |
| Selling and administrative expenses | 6.32%2.9B | 7.15%2.94B | 7.13%2.96B | -2.66%10.95B | -8.38%2.72B | -0.29%2.72B | -0.62%2.74B | -0.90%2.76B | -0.67%11.25B | -2.46%2.97B |
| Research and development costs | 6.10%713M | -2.38%698M | 4.59%684M | -5.09%2.74B | -3.45%700M | -14.07%672M | 4.53%715M | -6.17%654M | 5.32%2.89B | -4.86%725M |
| Depreciation amortization depletion | -5.24%470M | -5.42%471M | -3.87%472M | -2.33%1.97B | -3.02%481M | -0.40%496M | -1.78%498M | -4.10%491M | -1.66%2.01B | -3.50%496M |
| -Depreciation and amortization | -5.24%470M | -5.42%471M | -3.87%472M | -2.33%1.97B | -3.02%481M | -0.40%496M | -1.78%498M | -4.10%491M | -1.66%2.01B | -3.50%496M |
| Operating profit | 12.87%1.86B | 8.24%1.67B | -8.15%1.39B | -22.53%6.48B | 36.50%1.78B | -6.95%1.65B | -35.10%1.54B | -48.18%1.51B | -0.75%8.36B | -45.16%1.3B |
| Net non-operating interest income expense | 26.09%-51M | 4.92%-58M | -17.31%-61M | 32.80%-252M | -6.06%-70M | 19.77%-69M | 42.45%-61M | 55.56%-52M | 23.47%-375M | 45.00%-66M |
| Non-operating interest income | -6.19%91M | -16.33%82M | -20.79%80M | 110.38%385M | 1.14%89M | 76.36%97M | 276.92%98M | 621.43%101M | 325.58%183M | 700.00%88M |
| Non-operating interest expense | -14.46%142M | -11.95%140M | -7.84%141M | 14.16%637M | 3.25%159M | 17.73%166M | 20.45%159M | 16.79%153M | 4.69%558M | 17.56%154M |
| Other net income (expense) | 41.94%132M | -102.58%-4M | 5.71%111M | 37.30%438M | 3.66%85M | 25.68%93M | 89.02%155M | 29.63%105M | 15.58%319M | 18.84%82M |
| Gain on sale of security | 10.00%11M | 128.57%6M | ---- | -1,950.00%-41M | -271.43%-24M | 152.63%10M | ---21M | -300.00%-6M | -100.00%-2M | 133.33%14M |
| Other non- operating income (expenses) | 45.78%121M | -105.68%-10M | 0.00%111M | 49.22%479M | 60.29%109M | -10.75%83M | 114.63%176M | 42.31%111M | 15.88%321M | 7.94%68M |
| Income before tax | 16.10%1.94B | -1.77%1.61B | -8.07%1.44B | -19.77%6.66B | 35.98%1.8B | -4.95%1.67B | -30.44%1.64B | -45.69%1.56B | 1.16%8.31B | -43.27%1.32B |
| Income tax | 25.11%294M | 16.86%305M | -13.52%211M | -31.46%941M | -29.97%201M | -27.24%235M | -21.86%261M | -43.12%244M | 20.44%1.37B | -15.09%287M |
| Net income | 14.62%1.65B | -5.31%1.3B | -7.06%1.23B | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B |
| Net income continuous Operations | 14.62%1.65B | -5.31%1.3B | -7.06%1.23B | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 14.62%1.65B | -5.31%1.3B | -7.06%1.23B | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 14.62%1.65B | -5.31%1.3B | -7.06%1.23B | -17.45%5.72B | 54.31%1.59B | 0.07%1.44B | -31.86%1.38B | -46.14%1.32B | -1.95%6.93B | -48.06%1.03B |
| Basic earnings per share | 14.63%0.94 | -6.33%0.74 | -6.67%0.7 | -16.75%3.28 | 54.64%0.9192 | 0.00%0.82 | -31.30%0.79 | -45.65%0.75 | -0.76%3.94 | -47.28%0.5944 |
| Diluted earnings per share | 14.63%0.94 | -5.13%0.74 | -6.67%0.7 | -16.62%3.26 | 54.24%0.91 | 1.23%0.82 | -31.58%0.78 | -45.26%0.75 | -0.76%3.91 | -46.85%0.59 |
| Dividend per share | 7.84%0.55 | 7.84%0.55 | 7.84%0.55 | 8.51%2.04 | 8.51%0.51 | 8.51%0.51 | 8.51%0.51 | 8.51%0.51 | 4.44%1.88 | 4.44%0.47 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
